一个子空间学习辅助矩阵因子化用于药物重定向
Amir Mahdi Zhalefar1, Zahra Narimani1
1Department of Computer Science and Information Technology, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan 45137-66731, Iran.
BioImpacts : BI
|December 18, 2025
概括
这项研究引入了一种新的药物重定向方法,集成稀疏子空间学习和双图规范化. 该方法提高了预测准确性和有效性,用于识别现有药物的新用途.
科学领域:
- 计算生物学 计算生物学
- 生物信息学是一种生物信息学.
- 药物发现 药物发现 药物发现
背景情况:
- 药物开发是昂贵和耗时的.
- 机器学习和计算生物学提供先进的药物重新定位技术.
- 需要加强协同作用,以提高预测准确性和临床应用.
研究的目的:
- 提出一种新的方法,将稀疏子空间学习 (SLSDR) 和双域药物重定向方法 (iDrug) 整合在一起.
- 使用SLSDR增强iDrug目标功能,以从药物疾病和药物目标数据中改进特征提取.
- 开发一个整体的解决方案,以优化药物重新定位预测.
主要方法:
- 将特征选择技术SLSDR与用于药物重定向的iDrug方法集成.
- 在子空间学习和iDrug方法中使用矩阵分解.
- 构建基于SLSDR衍生特征的药物-药物,目标-目标和疾病-疾病相似性矩阵.
- 引入一种新的目标功能,以捕捉复杂的药物-疾病相互作用.
主要成果:
- 综合方法在预测准确度 (AUC,AUPR) 和计算效率方面提供了显著的收益.
- 与最先进的药物重新定位方法相比,证明了卓越的性能.
- 在特征和样本空间中保留数据几何.
结论:
- 拟议的矩阵因子化方法通过整合药物疾病和药物向领域知识来增强药物重定向.
- 与现有的最先进的方法相比,在药物重定位方面实现了更高的准确性.
相关概念视频
01:26Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
01:28Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
01:19Factors Affecting Drug Distribution: Miscellaneous Factors
923
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
923
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
434
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
434
02:52Predicting Products: Substitution vs. Elimination
13.7K
When a nucleophile and an alkyl halide react, nucleophilic substitution and β-elimination reactions compete to generate products.
The following factors can influence the mechanisms competing against each other:
The following factors can influence the mechanisms competing against each other:
13.7K